Innovations in controlled release drug delivery involving AbbVie and AstraZeneca were reported on August 26, 2025.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Innovations in controlled release drug delivery involving AbbVie and AstraZeneca were reported on August 26, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AbbVie, Astellas Pharma, and AstraZeneca announced partnerships for the Linzess drug's sales and development in various markets.Sub-event
AbbVie and AstraZeneca reported on innovations in controlled release drug delivery.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireControlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030 The controlled release drug delivery market offers substant